Blogs

Latest Blogs

EBF OS 2025: My Key Highlights

December 10, 2025

A unifying message across EBF 2025 was that bioanalytical science is transitioning from technical execution to decision support. For years, our industry has focused on…

Lipids as Biomarkers of Brain Disorders

March 24, 2022

Whilst the role of lipids has been particularly relevant within cardiovascular disease, their abundance in the body and high prevalence…

Synexa raises awareness for Rare Diseases Day

February 28, 2022

28 February 2022 marks Rare Disease Awareness Day and here at Synexa Life Sciences we are sharing our colours to…

The Biomarker Association between Depression and Vascular Disease

February 15, 2021

Major depressive disorder (MDD) has repeatedly emerged as a confounding or prognostic factor in the development of cardiovascular pathologies and…

Infertility and the importance of the endometrial immune balance

February 15, 2021

Infertility is defined by the World Health Organisation as the inability of a sexually active non-contracepting couple, to conceive after…

Th17 Cells and IL-17: a possible link between inflammation and neuronal decline in Multiple Sclerosis

September 18, 2020

Multiple sclerosis (MS) is an autoimmune and neurodegenerative disease of the central nervous system (CNS). A major component of the…

Spot on: Use of Dried Blood Spots (DBS) for serological immunoassays

September 18, 2020

Serological immunoassays provide a complementary approach to PCR-based molecular diagnostics in the detection and monitoring of the immune response of…